Palmoplantar psoriasis: A phenotypical and clinical review with introduction of a new quality-of-life assessment tool

被引:99
作者
Farley, Elizabeth [1 ]
Masrour, Shamin [1 ]
McKey, Joanna [1 ]
Menter, Alan [1 ]
机构
[1] Baylor Univ, Ctr Med, Waco, TX 76798 USA
关键词
hand and foot questionnaire; new assessment tool; palmoplantar psoriasis; phenotype; quality-of-life assessment tool; PALMAR PLANTAR PUSTULOSIS; CRITICAL-APPRAISAL; DISEASE SEVERITY; LESION PATTERN; WEIGHT-BEARING; DERMATOLOGY; ETRETINATE; DISABILITY; INFLIXIMAB; ACITRETIN;
D O I
10.1016/j.jaad.2008.11.910
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Palmoplantar psoriasis is associated with significant quality-of-life issues. Its epidemiology and phenotypical expression remain ill defined. Objective: We reviewed the literature and our clinical experience and developed a new quality-of-life assessment tool. Methods: We conducted a retrospective review of 150 patients with palmoplantar psoriasis. Results: In all, 78 (52%) patients displayed predominantly hyperkeratotic palmoplantar lesions, 24 (16%) pustular, 18 (12%) combination, and 30 (20%) had an indeterminate phenotype. In 27 (18%) patients, lesions were confined to the palms and soles. A new quality-of-life index was constructed to characterize disease severity. In all, 27 (18%) had mild, 72 (48%) moderate, and 51 (34%) severe disease involvement. Palmoplantar disease severity appeared independent from the degree of body surface area involvement. Limitations: This was a retrospective review. The quality-of-life index remains to be statistically verified in prospective clinical studies. Conclusion: Defining morphologic subtypes together with the use of a specific quality-of-life assessment tool in patients with palmoplantar psoriasis will improve our understanding and treatment of this recalcitrant form of psoriasis. (J Am Acad Dermatol 2009;60:1024-31.)
引用
收藏
页码:1024 / 1031
页数:8
相关论文
共 60 条
[1]  
Abramovits William, 2005, Skinmed, V4, P275
[2]  
Al-Mutairi Nawaf, 2005, J Drugs Dermatol, V4, P627
[3]   Palmoplantar pustulosis should not be considered as a variant of psoriasis [J].
Ammoury, A. ;
El Sayed, F. ;
Dhaybi, R. ;
Bazex, J. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2008, 22 (03) :392-393
[4]  
ANDREWS G, 1935, ARCH DERMATOL, V56, P766
[5]   Recalcitrant pustular eruptions of the palms and soles [J].
Andrews, GC ;
Birkman, FW ;
Kelly, RJ .
ARCHIVES OF DERMATOLOGY AND SYPHILOLOGY, 1934, 29 (04) :548-563
[6]   Quality of life measures in psoriasis: a critical appraisal of their quality [J].
Ashcroft, DM ;
Po, ALW ;
Williams, HC ;
Griffiths, CEM .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1998, 23 (05) :391-398
[7]  
Ashcroft DM, 1999, BRIT J DERMATOL, V141, P185
[8]   Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis [J].
Asumalahti, K ;
Ameen, M ;
Suomela, S ;
Hagforsen, E ;
Michaëlsson, G ;
Evans, J ;
Munro, M ;
Veal, C ;
Allen, M ;
Leman, J ;
Burden, AD ;
Kirby, B ;
Connolly, M ;
Griffiths, CEM ;
Trembath, RC ;
Kere, J ;
Saarialho-Kere, U ;
Barker, JNWN .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 120 (04) :627-632
[9]  
Barber HW., 1930, BRIT J DERMATOL, V42, P500, DOI DOI 10.1111/J.1365-2133.1930.TB09380.X
[10]   THE FOOT FUNCTION INDEX - A MEASURE OF FOOT PAIN AND DISABILITY [J].
BUDIMANMAK, E ;
CONRAD, KJ ;
ROACH, KE .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1991, 44 (06) :561-570